Search results
Results from the WOW.Com Content Network
St Jude Medical's Portico Transcatheter aortic valve received European CE mark approval in December 2013. The valve is repositionable before release to ensure accurate placement helping to improve patient outcomes. [12] Edwards' Sapien aortic valve is made from bovine pericardial tissue and is implanted via a catheter-based delivery system. It ...
St. Jude Medical Announces First Transapical Implant of Portico Transcatheter Aortic Heart Valve New surgical approach represents continued expansion of company's less invasive heart valve program ...
Aortic valve replacement is a cardiac surgery procedure whereby a failing aortic valve is replaced with an artificial heart valve. The aortic valve may need to be replaced because of aortic regurgitation (back flow), or if the valve is narrowed by stenosis .
In the US, UK and the European Union, the most common type of artificial heart valve is the bioprosthetic valve. Mechanical valves are more commonly used in Asia and Latin America. [citation needed] Companies that manufacture heart valves include Edwards Lifesciences, [5] Medtronic, [6] Abbott (St. Jude Medical), [7] CryoLife, [8] and LifeNet ...
The Trifecta (TM) Valve. (Photo: St. Jude Medical, Inc.) Conducted at 31 medical centers in the U.S., Canada and Europe, the study followed 1,014 eligible patients implanted with the Trifecta ...
St. Jude Medical Announces European Approval of the Portico Transcatheter Aortic Heart Valve ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) , a global medical device company ...
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
In 1976, he founded St. Jude Medical where his team engineered the first bileaflet mechanical heart valve, which reduced the frequency of blood clots in patients. It still dominates the mechanical valve replacement market. [4] [5] In 1982, Villafana founded GV Medical, which developed a device to open blood vessels open. [6]